Why Smart Patients Compare Wegovy vs Mounjaro Pricing First
Wegovy Compared to Mounjaro: Exclusive Discount Codes Explained
When evaluating Wegovy compared to Mounjaro, pricing transparency matters most to UK patients. EverydayMeds offers both treatments with substantial discount codes applied directly at checkout. New customers benefit from code FIRST40, while returning patients use DOSE25 to access our competitive pricing structure. These codes automatically reduce your treatment costs to the advertised prices, making premium weight management accessible.
The discount application process is seamless through our secure checkout system. Simply complete your clinical assessment, receive prescriber approval, then apply your relevant code during payment. Both Wegovy and Mounjaro qualify for these savings, ensuring you get the same financial benefits regardless of which prescription-only medicine your prescriber recommends.
Wegovy Compared to Mounjaro: Complete UK Pricing Breakdown
Wegovy pricing starts at £79.99 for the essential 0.25mg starter pen, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the maintenance 2.4mg dose. Our bundle options provide treatment continuity, including the Intro Duo (0.25mg & 0.5mg) at £169.99 and the Gentle Start Trio at £269.99. Each price reflects the discount code application, eliminating surprise costs.
Mounjaro follows a different pricing structure due to its dual-agonist formulation, though both treatments require the same rigorous clinical assessment process. Payment is secured through our encrypted system, with next-day cold-chain delivery ensuring your prescription-only medicine maintains optimal potency. Both treatments are available through our GPhC #9012878 registered service.
Clinical Evidence: Wegovy Compared to Mounjaro Trial Data
In clinical trials, Wegovy demonstrated significant weight management support when used alongside a reduced-calorie diet and increased physical activity. The STEP 1 trial showed approximately 15% average weight loss at 68 weeks, while the SELECT cardiovascular outcomes study revealed a 20% reduction in major cardiovascular events (Wilding et al., NEJM, 2021). These results established Wegovy's evidence base for UK licensing.
Mounjaro's clinical profile stems from its dual GIP and GLP-1 receptor mechanism, offering a different approach to weight management support. Both treatments require ongoing commitment to lifestyle modifications, and individual results may vary significantly. Your prescriber can evaluate which evidence base aligns better with your specific health profile and treatment goals.
How Wegovy Works: GLP-1 Mechanism Explained Simply
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to support weight management. The medication works on brain appetite centres, potentially reducing food cravings and promoting feelings of fullness after smaller meals. This biological mechanism supports patients in maintaining a reduced-calorie diet more comfortably. The once-weekly FlexTouch pen delivers consistent medication levels, making treatment adherence straightforward. Each dose must follow the prescribed escalation schedule to minimise potential side effects while maximising therapeutic benefits.
EverydayMeds Ordering Process: Assessment to Delivery
Our streamlined process begins with a comprehensive 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. A qualified prescriber reviews your submission within 3 working days (24 hours with express service), ensuring clinical appropriateness for either Wegovy or Mounjaro. Upon approval, your prescription-only medicine ships via next-day cold-chain delivery to maintain temperature integrity. Our GPhC-registered pharmacy team coordinates every step from clinical review through final delivery. The entire process prioritises both clinical safety and treatment accessibility for UK patients.
Storage Advantages: Wegovy Compared to Mounjaro Practicality
Wegovy offers superior storage flexibility with 6 weeks room temperature stability below 30°C once removed from refrigeration, compared to Mounjaro's 21-day limit. This advantage proves invaluable for travel, work schedules, or temporary fridge issues without compromising medication effectiveness. Both treatments require 2-8°C refrigeration before first use, delivered in temperature-controlled packaging. The FlexTouch pen design ensures accurate dosing throughout the escalation schedule from 0.25mg through 2.4mg maintenance. Proper storage maintains medication potency and reduces waste from temperature exposure.
Wegovy Compared to Mounjaro: Making the Right Choice with Discount Codes
Smart patients recognise that choosing between Wegovy and Mounjaro involves both clinical and financial considerations. Our discount codes FIRST40 and DOSE25 ensure both treatments remain accessible, removing cost as the primary deciding factor. This approach allows your prescriber to focus purely on clinical suitability rather than pricing concerns.
The decision ultimately rests on individual response patterns, storage requirements, and prescriber recommendations based on your complete health profile. Both treatments are available through our secure platform with identical service standards, prescription review processes, and delivery options for UK patients seeking professional weight management support.
Start Your Treatment Today: Apply Discount Codes at Checkout
Ready to begin your weight management journey with professional clinical support? Simply complete our online assessment, receive prescriber approval, then apply code FIRST40 (new customers) or DOSE25 (returning customers) at checkout to access our competitive pricing. Your prescription-only medicine ships next-day with full temperature control and discrete packaging. Both Wegovy and Mounjaro are available through our comprehensive service, backed by ongoing clinical support throughout your treatment journey. Take the first step towards sustainable weight management with EverydayMeds' trusted, GPhC-registered service.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
